WHITE PAPER: The CEESP Economic Evaluation: Can Clinical Efficacy and Cost-effectiveness Co-exist in France?

The emergence of economic appraisals conducted by the Commission Évaluation Économique et de Santé Publique (CEESP) represents an important development in attaining market access to France. As of October 2013, manufacturers of certain innovative products are required to submit to an economic evaluation from the (CEESP) in addition to the…

Poster at ISPOR international on the role of indirect comparisons in the AMNOG evaluation procedure

The AMNOG assessment procedure requires that manufacturers submit indirect comparisons for the evaluation of molecules in the absence of the availability of direct comparisons versus the G-BA designated appropriate comparator(s). Although guidelines have been established on how indirect comparisons should be structured and carried out, the methodological robustness sought by…